Interventional Cardiology Devices Market Report by Product (Stents, Interventional Catheters, PTCA Guidewires, Balloon Inflation Device, PTCA Balloons), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032

Interventional Cardiology Devices Market Report by Product (Stents, Interventional Catheters, PTCA Guidewires, Balloon Inflation Device, PTCA Balloons), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032

The global interventional cardiology devices market size reached US$ 22.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 41.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032.

Interventional cardiology devices refer to the medical equipment and guiding tools used for performing cardiovascular procedures, such as angioplasty and stenting. Some of the commonly used devices include angioplasty balloons, stents, mitral, pulmonary and tricuspid valves, catheters, plaque modification and hemodynamic flow alteration devices. Along with this, guidewires, vascular closure and hemostasis devices and introducer sheaths are also utilized. These tools and devices are widely used for medical procedures, such as coronary artery bypass grafting (CABG), trans-myocardial laser revascularization (TMR), arrhythmia treatment, aneurysm repair, open-heart, off-pump heart and minimally invasive (MI) heart surgeries. They are also used for other procedures, such as atherectomy, embolic protection and percutaneous valve repair.

Interventional Cardiology Devices Market Trends:
The increasing prevalence of diabetes, hypertension and cardiovascular disorders, such as coronary artery disease (CAD, is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Interventional cardiology and embolic protection devices are widely used to capture embolic debris to ensure continuous blood flow and preventing blockages. Additionally, the development of innovative bioabsorbable and drug-eluting stents, pacemakers and drug-coated mesh tubes is acting as another growth-inducing factor. In line with this, the increasing utilization of advanced imaging solutions, such as intravenous ultrasound (IVUS), fractional flow reserve (FFR) and optical coherence tomography (OCT) for early diagnosis and timely treatment of cardiovascular ailments, is also contributing to the growth of the market. Other factors, including rising healthcare expenditure capacities of the masses, along with extensive improvements in the medical infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global interventional cardiology devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and end user.

Breakup by Product:

Stents
Drug Eluting Stents
Bare Metal Stents
Bio-Absorbable Stents
Interventional Catheters
IVUS Catheters
Guiding Catheters
Angiography Catheters
PTCA Guidewires
Balloon Inflation Device
PTCA Balloons
Cutting Balloons
Scoring Balloons
Drug Eluting Balloons
Normal Balloons

Breakup by End User:

Hospitals
Ambulatory Surgical Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Alvimedica, B. Braun Melsungen AG, Biosensors International Group Ltd. (Bluesail Medical Co. Ltd.), BIOTRONIK Inc., Boston Scientific Corporation, Cook Group Incorporated, ENDOCOR GmbH, Koninklijke Philips N.V., Medinol Ltd., Medtronic plc and Terumo Corporation.

Key Questions Answered in This Report

1. What was the size of the global interventional cardiology devices market in 2023?
2. What is the expected growth rate of the global interventional cardiology devices market during 2024-2032?
3. What are the key factors driving the global interventional cardiology devices market?
4. What has been the impact of COVID-19 on the global interventional cardiology devices market?
5. What is the breakup of the global interventional cardiology devices market based on the product?
6. What is the breakup of the global interventional cardiology devices market based on the end user?
7. What are the key regions in the global interventional cardiology devices market?
8. Who are the key players/companies in the global interventional cardiology devices market?